Hochmeister Sonja, Aeinehband Shahin, Dorris Charles, Berglund Rasmus, Haindl Michaela T, Velikic Vid, Gustafsson Sven A, Olsson Tomas, Piehl Fredrik, Jagodic Maja, Zeitelhofer Manuel, Adzemovic Milena Z
Department of General Neurology, Medical University of Graz, Graz, Austria.
Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Front Neurol. 2020 Nov 13;11:600401. doi: 10.3389/fneur.2020.600401. eCollection 2020.
An increasing body of evidence associates low vitamin D levels with increased risk of multiple sclerosis (MS), suggesting the possibility of a gene-environment interaction for this environmental factor in MS pathogenesis. Moreover, it has been shown that vitamin D downregulates major histocompatibility complex (MHC) class II expression in experimental autoimmune encephalomyelitis (EAE), an animal model of MS. We here report about the impact of a dietary vitamin D supplementation on EAE in the rat strains having functionally relevant allelic variations in the () gene, a master regulator of MHC class II expression. Full length myelin oligodendrocyte glycoprotein (MOG)-EAE was induced in DA.PVG- congenic rats harboring the locus from PVG strain in the EAE- susceptible DA background, and compared to the parental strains. The congenic rats fed with either vitamin D supplemented, deprived or regular diet developed an intermediate clinical EAE phenotype, in contrast to DA and PVG strains. Immunopathological studies revealed vitamin D dose-dependent effect on demyelination and inflammatory infiltration of the central nervous system (CNS), expression of MHC class II and CIITA, as well as downregulation of a range of pro-inflammatory genes. Taken together, our findings demonstrate an impact of vitamin D on the target tissue pathology and peripheral immune response during EAE in DA.PVG- congenic strain. Thereby, our data provide evidence of a modulatory effect of vitamin D in context of genetic variances in the locus/ gene in MS-like neuroinflammation, with potential relevance for the human demyelinating disease.
越来越多的证据表明,低维生素D水平与多发性硬化症(MS)风险增加有关,这表明在MS发病机制中,这种环境因素可能存在基因-环境相互作用。此外,研究表明,在实验性自身免疫性脑脊髓炎(EAE,一种MS动物模型)中,维生素D可下调主要组织相容性复合体(MHC)II类分子的表达。我们在此报告饮食中补充维生素D对具有MHC II类分子表达主要调节因子()基因功能相关等位基因变异的大鼠品系EAE的影响。在易患EAE的DA背景中携带PVG品系基因座的DA.PVG同源大鼠中诱导全长髓鞘少突胶质细胞糖蛋白(MOG)-EAE,并与亲本品系进行比较。与DA和PVG品系相比,喂食补充维生素D、缺乏维生素D或常规饮食的同源大鼠出现了中度临床EAE表型。免疫病理学研究显示,维生素D对中枢神经系统(CNS)的脱髓鞘和炎症浸润、MHC II类分子和CIITA的表达以及一系列促炎基因的下调具有剂量依赖性作用。综上所述,我们的研究结果表明维生素D对DA.PVG同源品系EAE期间的靶组织病理学和外周免疫反应有影响。因此,我们的数据提供了证据,证明在MS样神经炎症中,维生素D在基因座/基因遗传变异的背景下具有调节作用,这对人类脱髓鞘疾病可能具有相关性。